This dataset was a lung cancer cohort, containing normal individuals, those with epidermal growth factor receptor (EGFR) mutations, anaplastic lymphoma kinase (ALK) mutations, RAS mutations and wild type lung adenocarcinoma at different stages. Here, ALK is linked to lung adenocarcinoma.